3-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid, 95.0%, 1g

Boc-D-Lys(2-Cl-Z)-OH, 95%, 1g

4,5,6,7-tetrahydroisoxazolo[4,3-c]pyridine hydrochloride, 95.0%, 500mg

6-(2,3,3-Trimethyl-3H-indol-1-ium-1-yl)hexanoate hydrobromide, 95%, 25g

Methyl 6-hydrazinylpyridazine-3-carboxylate dihydrochloride, 95.0%, 25g

Strontium fluoride, 99.0%, 100g

GC capillary column ROTI®Cap-1, 25 m, 0.32 mm, 0.10 µm, 1 Piece(s)

Methyl (3E)-1-acetyl-3-[methoxy(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate, 96.0%, 5g

3,5-Difluoro-N-methylpyridin-2-amine, 95%, 250mg

6-bromo-5-methyl-3H,4H-thieno[2,3-d]pyrimidin-4-one, 1g

Benzyl (S,S,S)-2-Azabicyclo[3.3.0]octane-3-carboxylate Hydrochloride>98.0%(HPLC)(T)1g

N'-(7-chloro-4-methoxy-1,3-benzothiazol-2-yl)-N,N-dimethylpropane-1,3-diamine, 95.0%, 250mg

Ethyl-2-amino-4-methyloxazole-5-carboxylate, 95.0%, 250mg